Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Moderate to Severe Facial Acne Vulgaris

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Must be between 12 and 45 years of age.~* Has a diagnosis of moderate to severe facial acne vulgaris with no more than two nodules on the face~Exclusion Criteria:~* Is allergic to tetracycline-class antibiotics or to any ingredient in the study medication.~* Has a history of pseudomembranous colitis or antibiotic-associated colitis.~* Has a history of hepatitis or liver damage or renal impairment.

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Doxycyline 0.6 mg/kg/day (Type: EXPERIMENTAL): Doxycycline dosed at 40 mg/day to subjects of appropriate weights
- Doxycycline 1.2 mg/kg/day (Type: EXPERIMENTAL): Doxycycline dosed at 80 mg/day to subjects of appropriate weights
- Doxycycline 2.4 mg/kg/day (Type: EXPERIMENTAL): Doxycycline dosed at 160 mg/day to subjects of appropriate weights
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).